Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Pemetrexed × Clear all

NCT06630325 2026-01-07

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase 2 Active not recruiting

GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT00864513 2015-12-08

Study of Pemetrexed for Second-Line Pancreas Cancer

Phase 2 Terminated

17 enrolled 9 charts

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT00490373 2007-06-22

Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms